All stock lists
SL Science Holding Ltd (NASDAQ:SLBT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.19+0.04 (+3.04%)
Insider Score
––Not scored
SLBT Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
SLBT Income Statement
| Fiscal Period | Q2 2025 | Q1 2025 |
|---|---|---|
| Period Ending | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 564.62 | 564.62 |
| Revenue Growth (YoY) | — | — |
| Cost of Revenue | 370.09 | 370.09 |
| Gross Profit | 194.53 | 194.53 |
| SG&A Expense | 640.89 | 640.89 |
| R&D Expense | 358.51 | 358.51 |
| Operating Expenses | 999.40 | 999.40 |
| Operating Income | -804.00 | -804.00 |
| Pretax Income | -801.00 | -801.00 |
| Tax Provision | 0.00 | 0.00 |
| Net Income | -801.00 | -801.00 |
| EPS (Basic) | -0.22 | -0.22 |
| EPS (Diluted) | -0.22 | -0.22 |
| Shares Outstanding | 3.67 K | 3.67 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.